Bullish Biotech Bets After Positive Attention
October 05, 2017 at 12:30 PM EDT
Biotechnology ETFs have been getting plenty of positive attention in recent weeks, a trend that certainly extends to the SPDR S&P Biotech ETF (NYSEArca: XBI). The equal-weight XBI, the second-largest biotech ETF by assets, is up more than 40% year-to-date, making it one of this year’s...